HotSpot Therapeutics, Inc. v. Nurix Therapeutics, Inc.

1 UNITED STATES DISTRICT COURT 2 NORTHERN DISTRICT OF CALIFORNIA 3 4 HOTSPOT THERAPEUTICS, INC., Case No. 22-cv-04109-TSH 5 Plaintiff, 6 y. ORDER TO SHOW CAUSE 7 NURIX THERAPEUTICS, INC., 8 Defendant. 9 10 Plaintiff/Counterclaim Defendant HotSpot Therapeutics, Inc. moves for partial summary 11 || judgment in its favor that Defendant/Counterclaim Plaintiff Nurix Therapeutics, Inc.’s trade secret (12 misappropriation claims are barred by the applicable three-year statute of limitations. ECF No. 5 13 189. Nurix failed to file an opposition in compliance with Civil Local Rule 7. The Court 14 || possesses the inherent power to dismiss an action sua sponte “to achieve the orderly and 3 15. || expeditious disposition of cases.” Link v. Wabash R.R. Co., 370 U.S. 626, 629-33 (1962). 16 Accordingly, the Court hereby VACATES the March 14, 2024 noticed hearing date and 5 7 ORDERS Nurix to show cause why its claims should not be dismissed for failure to prosecute and 5 18 failure to comply with court…